Healthpeak REIT Rg
DOC
USD
STOCK MARKET:
NYX
Closed
 
...
Price in deferred time of 15 minutes
Last quote
04/18/2024 - 16:15:00
Bid
04/18/2024 - 16:00:00
Bid
Volume
Ask
04/18/2024 - 16:00:00
Ask
Volume
18.01
-0.06 ( -0.33% )
18.00
16,400
18.01
35,800
More information
Analysis by TheScreener
16.04.2024
Evaluation Neutral  
Interest Strong  
Sensibility Middle  
Analysis date: 16.04.2024
Global Evaluation
  Neutral
The stock is classified in the neutral zone since 08.03.2024.
Interest
  Strong
Strong interest since 22.03.2024.
Earnings Rev Trend
  Negative
 
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 29.03.2024 at a price of 18.75.
Evaluation
  Undervalued
 
Based on its growth potential and our own criteria, at its current price the stock is moderately undervalued.
MT Tech Trend
  Neutral
 
The stock is currently trading close to its forty day moving average (changes between +1.75% and -1.75% are considered neutral). Prior to this (since 29.03.2024), the stock traded above its moving average. The confirmed Technical Reverse point (Tech Reverse - 1.75%) is 17.779.
4wk Rel Perf
  4.79%
 
The four week relative overperformance versus SP500 is 4.79%.
Sensibility
  Middle
The stock has been on the moderate-sensitivity level since 08.03.2024.
Bear Market Factor
  Middle
On average, the stock is likely to decline with the index.
Bad News Factor
  Low
When the stock's pressure is specific, the market sanction on average is 3.01%.
Mkt Cap in $bn
  13.07
With a market capitalization >$8bn, HEALTHPEAK PROPERTIES is considered a large-cap stock.
G/PE Ratio
  0.95
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 0.9 indicates that the stock's price presents a discount to growth of .
LT P/E
  29.85
The estimated PE is for the year 2025.
LT Growth
  21.66%
The annualized growth estimate is for the current year to 2025.
Avg. Nb analysts
  6
Over the last seven weeks, an average of 6 analysts provided earnings per share estimates.
Dividend Yield
  6.78%
The earnings forecasts are not sufficient to cover the twelve month estimated dividend.
Beta
  116
For 1% of index variation, the stock varies on average by 1.16%.
Correlation
  0.48
47.50% of stock movements are explained by index variations.
Value at Risk
  2.51
The value at risk is estimated at USD 2.51. The risk is therefore 14.10%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
  02.01.2002